{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T07:42:01Z","timestamp":1781250121985,"version":"3.54.1"},"reference-count":88,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","jiac-j.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.jiac.2024.07.006","type":"journal-article","created":{"date-parts":[[2024,7,6]],"date-time":"2024-07-06T16:30:33Z","timestamp":1720283433000},"page":"959-970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Are secondary bacterial pneumonia mortalities increased because of insufficient pro-resolving mediators?"],"prefix":"10.1016","volume":"30","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4843-9835","authenticated-orcid":false,"given":"Kevin","family":"Roe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2024.07.006_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006770","article-title":"Influenza interaction with cocirculating pathogens and its impact on surveillance, pathogenesis, and epidemic profile: a key role for mathematical modelling","volume":"14","author":"Opatowski","year":"2018","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jiac.2024.07.006_bib2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fcimb.2018.00343","article-title":"Back to the future: lessons learned from the 1918 influenza pandemic","volume":"8","author":"Short","year":"2018","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jiac.2024.07.006_bib3","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3389\/fmicb.2017.01041","article-title":"Secondary bacterial infections associated with influenza pandemics","volume":"8","author":"Morris","year":"2017","journal-title":"Front Microbiol"},{"issue":"7","key":"10.1016\/j.jiac.2024.07.006_bib4","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1086\/591708","article-title":"Predominant role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness","volume":"198","author":"Morens","year":"2008","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.006_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijid.2023.04.003","article-title":"Determinants of poor clinical outcome in patients with influenza pneumonia: a systematic review and meta-analysis","volume":"131","author":"Arranz-Herrero","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.006_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.pharmthera.2017.12.008","article-title":"Prostaglandin E2 as a regulator of immunity to pathogens","volume":"185","author":"Mart\u00ednez-Col\u00f3n","year":"2018","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jiac.2024.07.006_bib7","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/327568","article-title":"Prostaglandin E2 and the suppression of phagocyte innate immune responses in different organs","author":"Medeiros","year":"2012","journal-title":"Mediat Inflamm"},{"issue":"8","key":"10.1016\/j.jiac.2024.07.006_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00095-21","article-title":"Roles of eicosanoids in regulating inflammation and neutrophil migration as an innate host response to bacterial infections","volume":"89","author":"Sheppe","year":"2021","journal-title":"Infect Immun"},{"issue":"1","key":"10.1016\/j.jiac.2024.07.006_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/s41392-020-00443-w","article-title":"Metabolism pathways of arachidonic acids: mechanisms and potential therapeutic targets","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"issue":"1","key":"10.1016\/j.jiac.2024.07.006_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s12079-021-00630-6","article-title":"A review of non-prostanoid, eicosanoid receptors: expression, characterization, regulation, and mechanism of action","volume":"16","author":"Biringer","year":"2022","journal-title":"J Cell Commun Signal"},{"issue":"9","key":"10.1016\/j.jiac.2024.07.006_bib11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/intimm\/dxz021","article-title":"Molecular mechanisms underlying prostaglandin E2-exacerbated inflammation and immune diseases","volume":"31","author":"Tsuge","year":"2019","journal-title":"Int Immunol"},{"key":"10.1016\/j.jiac.2024.07.006_bib12","doi-asserted-by":"crossref","first-page":"a016311","DOI":"10.1101\/cshperspect.a016311","article-title":"Lipid mediators in the resolution of inflammation","volume":"7","author":"Serhan","year":"2015","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"6","key":"10.1016\/j.jiac.2024.07.006_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/microbiolspec.MCHD-0035-2016","article-title":"Lipid mediators in inflammation","volume":"4","author":"Bennett","year":"2016","journal-title":"Microbiol Spectr"},{"issue":"3","key":"10.1016\/j.jiac.2024.07.006_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1042\/EBC20200018","article-title":"Specialized pro-resolving mediator network: an update on production and actions","volume":"64","author":"Chiang","year":"2020","journal-title":"Essays Biochem"},{"issue":"21","key":"10.1016\/j.jiac.2024.07.006_bib15","doi-asserted-by":"crossref","first-page":"35033","DOI":"10.18632\/oncotarget.16591","article-title":"A potential anti-tumor effect of leukotriene C4 through the induction of 15-hydroxyprostaglandin dehydrogenase expression in colon cancer cells","volume":"8","author":"Mehdawi","year":"2017","journal-title":"Oncotarget"},{"issue":"27","key":"10.1016\/j.jiac.2024.07.006_bib16","doi-asserted-by":"crossref","first-page":"10675","DOI":"10.1074\/jbc.RA117.001297","article-title":"GPR40 is a low-affinity epoxyeicosatrienoic acid receptor in vascular cells","volume":"293","author":"Park","year":"2018","journal-title":"J Biol Chem"},{"key":"10.1016\/j.jiac.2024.07.006_bib17","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.3389\/fphar.2018.01273","article-title":"Lipoxin and resolvin receptors transducing the resolution of inflammation in cardiovascular disease","volume":"9","author":"Pirault","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jiac.2024.07.006_bib18","doi-asserted-by":"crossref","first-page":"595","DOI":"10.4049\/jimmunol.174.2.595","article-title":"Cutting edge: macrophage inhibition by cyclic AMP (cAMP): differential roles of protein kinase A and exchange protein directly activated by cAMP-1","volume":"174","author":"Aronoff","year":"2005","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jiac.2024.07.006_bib19","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/1753425916684934","article-title":"Efferocytosis-induced prostaglandin E2 production impairs alveolar macrophage effector functions during Streptococcus pneumoniae infection","volume":"23","author":"Salina","year":"2017","journal-title":"Innate Immun"},{"key":"10.1016\/j.jiac.2024.07.006_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.3389\/fcimb.2013.00045","article-title":"PGE(2) suppression of innate immunity during mucosal bacterial infection","volume":"3","author":"Agard","year":"2013","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/j.jiac.2024.07.006_bib21","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3389\/fphys.2017.00089","article-title":"Prostaglandin E2 as a modulator of viral infections","volume":"8","author":"Sander","year":"2017","journal-title":"Front Physiol"},{"issue":"4","key":"10.1016\/j.jiac.2024.07.006_bib22","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1124\/pr.120.019331","article-title":"International union of basic and clinical pharmacology. CIX. Differences and similarities between human and rodent prostaglandin E2 receptors (EP1-4) and prostacyclin receptor (IP): specific roles in pathophysiologic conditions","volume":"72","author":"Norel","year":"2020","journal-title":"Pharmacol Rev"},{"issue":"1","key":"10.1016\/j.jiac.2024.07.006_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/aji.12153","article-title":"EP4 and EP2 receptor activation of protein kinase A by prostaglandin E2 impairs macrophage phagocytosis of Clostridium sordellii","volume":"71","author":"Rogers","year":"2014","journal-title":"Am J Reprod Immunol"},{"key":"10.1016\/j.jiac.2024.07.006_bib24","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/ncomms2684","article-title":"Prostaglandin E\u2082 promotes Th1 differentiation via synergistic amplification of IL-12 signalling by cAMP and PI3-kinase","volume":"4","author":"Yao","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jiac.2024.07.006_bib25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.12688\/f1000research.13426.1","article-title":"NFAT control of immune function: new frontiers for an abiding trooper","volume":"7","author":"Vaeth","year":"2018","journal-title":"F1000Res"},{"key":"10.1016\/j.jiac.2024.07.006_bib26","article-title":"Postoperative natural killer cell dysfunction: the prime suspect in the case of metastasis following curative cancer surgery","volume":"s","author":"Market","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.jiac.2024.07.006_bib27","doi-asserted-by":"crossref","DOI":"10.4161\/onci.22647","article-title":"A prostaglandin E (PGE) receptor EP4 antagonist protects natural killer cells from PGE2-mediated immunosuppression and inhibits breast cancer metastasis","volume":"2","author":"Ma","year":"2013","journal-title":"OncoImmunology"},{"issue":"3","key":"10.1016\/j.jiac.2024.07.006_bib28","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.tibs.2018.10.007","article-title":"Eicosanoid and specialized proresolving mediator regulation of lymphoid cells","volume":"44","author":"Wei","year":"2019","journal-title":"Trends Biochem Sci"},{"issue":"5","key":"10.1016\/j.jiac.2024.07.006_bib29","doi-asserted-by":"crossref","first-page":"449","DOI":"10.4168\/aair.2014.6.5.449","article-title":"Prostaglandin E2 induces IL-6 and IL-8 production by the EP receptors\/akt\/NF-\u03baB pathways in nasal polyp-derived fibroblasts","volume":"6","author":"Cho","year":"2014","journal-title":"Allergy Asthma Immunol Res"},{"issue":"12","key":"10.1016\/j.jiac.2024.07.006_bib30","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.4049\/jimmunol.1900201","article-title":"Prostaglandin E2 inhibits the ability of neutrophils to kill Listeria monocytogenes","volume":"202","author":"Pitts","year":"2019","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jiac.2024.07.006_bib31","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41423-020-00541-3","article-title":"Macrophages and the maintenance of homeostasis","volume":"18","author":"Mosser","year":"2021","journal-title":"Cell Mol Immunol"},{"issue":"7","key":"10.1016\/j.jiac.2024.07.006_bib32","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/JTO.0b013e3182542752","article-title":"Interleukin-17 and prostaglandin E2 are involved in formation of an M2 macrophage-dominant microenvironment in lung cancer","volume":"7","author":"Liu","year":"2012","journal-title":"J Thorac Oncol"},{"issue":"1","key":"10.1016\/j.jiac.2024.07.006_bib33","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1073\/pnas.1610242114","article-title":"Pseudomonas aeruginosa sabotages the generation of host proresolving lipid mediators","volume":"114","author":"Flitter","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"10.1016\/j.jiac.2024.07.006_bib34","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.bbalip.2014.07.008","article-title":"Prostaglandin E2-induced inflammation: relevance of prostaglandin E receptors","volume":"1851","author":"Kawahara","year":"2015","journal-title":"Biochim Biophys Acta"},{"issue":"11","key":"10.1016\/j.jiac.2024.07.006_bib35","doi-asserted-by":"crossref","first-page":"L1111","DOI":"10.1152\/ajplung.00220.2015","article-title":"Increased lethality and defective pulmonary clearance of Streptococcus pneumoniae in microsomal prostaglandin E synthase-1-knockout mice","volume":"310","author":"Dolan","year":"2016","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"2","key":"10.1016\/j.jiac.2024.07.006_bib36","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/iid3.295","article-title":"Human mast cells exhibit an individualized pattern of antimicrobial responses","volume":"8","author":"Garcia-Rodriguez","year":"2020","journal-title":"Immun Inflamm Dis"},{"issue":"2","key":"10.1016\/j.jiac.2024.07.006_bib37","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1189\/jlb.4MR0617-227RR","article-title":"Group A streptococcal pharyngitis: immune responses involved in bacterial clearance and GAS-associated immunopathologies","volume":"103","author":"Soderholm","year":"2018","journal-title":"J Leukoc Biol"},{"issue":"4","key":"10.1016\/j.jiac.2024.07.006_bib38","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.4049\/jimmunol.1202932","article-title":"Leukotriene B4 enhances innate immune defense against the puerperal sepsis agent Streptococcus pyogenes","volume":"190","author":"Soares","year":"2013","journal-title":"J Immunol"},{"issue":"4","key":"10.1016\/j.jiac.2024.07.006_bib39","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.4049\/jimmunol.1000838","article-title":"Inducible cyclooxygenase released prostaglandin E2 modulates the severity of infection caused by Streptococcus pyogenes","volume":"185","author":"Goldmann","year":"2010","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.jiac.2024.07.006_bib40","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3390\/nu14030503","article-title":"Carvacrol suppresses inflammatory biomarkers production by lipoteichoic acid- and peptidoglycan-stimulated human tonsil epithelial cells","volume":"14","author":"Wijesundara","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/j.jiac.2024.07.006_bib41","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/706376","article-title":"The lung immune response to nontypeable Haemophilus influenzae (lung immunity to NTHi)","volume":"2015","author":"King","year":"2015","journal-title":"J Immunol Res"},{"issue":"1","key":"10.1016\/j.jiac.2024.07.006_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-46692-x","article-title":"Characterization of respiratory bacterial co-infection and assessment of empirical antibiotic treatment in patients with COVID-19 at hospital admission","volume":"13","author":"Antuori","year":"2023","journal-title":"Sci Rep"},{"issue":"8","key":"10.1016\/j.jiac.2024.07.006_bib43","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1128\/IAI.02060-14","article-title":"Francisella tularensis LVS induction of prostaglandin biosynthesis by infected macrophages requires specific host phospholipases and lipid phosphatases","volume":"82","author":"Navratil","year":"2014","journal-title":"Infect Immun"},{"key":"10.1016\/j.jiac.2024.07.006_bib44","first-page":"249","article-title":"Host signal transduction and protein kinases implicated in Legionella infection","volume":"376","author":"Hempstead","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.jiac.2024.07.006_bib45","article-title":"Eicosanoid pathway on host resistance and inflammation during Mycobacterium tuberculosis infection is comprised by LTB","volume":"866","author":"Sorgi","year":"2020","journal-title":"Biochim Biophys Acta, Mol Basis Dis"},{"key":"10.1016\/j.jiac.2024.07.006_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006874","article-title":"Lipid droplet formation in Mycobacterium tuberculosis infected macrophages requires IFN-g\/HIF-1a signaling and supports host defense","volume":"14","author":"Knight","year":"2018","journal-title":"PLoS Pathog"},{"issue":"1","key":"10.1016\/j.jiac.2024.07.006_bib47","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1186\/s12931-021-01792-y","article-title":"Role of specialized pro-resolving lipid mediators in pulmonary inflammation diseases: mechanisms and development","volume":"22","author":"Yang","year":"2021","journal-title":"Respir Res"},{"key":"10.1016\/j.jiac.2024.07.006_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175963","article-title":"The vasoconstrictor activities of prostaglandin D2 via the thromboxane prostanoid receptor and E prostanoid receptor-3 outweigh its concurrent vasodepressor effect mainly through D prostanoid receptor-1 ex vivo and in vivo","volume":"956","author":"Guo","year":"2023","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jiac.2024.07.006_bib49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.3389\/fphar.2010.00116","article-title":"PG F(2\u03b1) receptor: a promising therapeutic target for cardiovascular disease","volume":"1","author":"Zhang","year":"2010","journal-title":"Front Pharmacol"},{"issue":"4","key":"10.1016\/j.jiac.2024.07.006_bib50","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1165\/rcmb.2018-0175OC","article-title":"Leukotriene A4 hydrolase activation and leukotriene B4 production by eosinophils in severe asthma","volume":"60","author":"Pal","year":"2019","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"8","key":"10.1016\/j.jiac.2024.07.006_bib51","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002390","article-title":"The pivotal role of 5-lipoxygenase-derived LTB4 in controlling pulmonary paracoccidioidomycosis","volume":"7","author":"Santos","year":"2013","journal-title":"PLoS Neglected Trop Dis"},{"issue":"10","key":"10.1016\/j.jiac.2024.07.006_bib52","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.105247","article-title":"Structural diversity of leukotriene G-protein coupled receptors","volume":"299","author":"Luginina","year":"2023","journal-title":"J Biol Chem"},{"issue":"7","key":"10.1016\/j.jiac.2024.07.006_bib53","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.1172\/JCI97946","article-title":"Leukotriene receptors as potential therapeutic targets","volume":"128","author":"Yokomizo","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jiac.2024.07.006_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2022.101597","article-title":"E-series resolvin metabolome, biosynthesis and critical role of stereochemistry of specialized pro-resolving mediators (SPMs) in inflammation-resolution: preparing SPMs for long COVID-19, human clinical trials, and targeted precision nutrition","volume":"59","author":"Serhan","year":"2022","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jiac.2024.07.006_bib55","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.mam.2017.03.005","article-title":"Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors","volume":"58","author":"Chiang","year":"2017","journal-title":"Mol Aspect Med"},{"issue":"2","key":"10.1016\/j.jiac.2024.07.006_bib56","doi-asserted-by":"crossref","first-page":"L350","DOI":"10.1152\/ajplung.00038.2017","article-title":"EETs promote hypoxic pulmonary vasoconstriction via constrictor prostanoids","volume":"313","author":"Kandhi","year":"2017","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"1","key":"10.1016\/j.jiac.2024.07.006_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-96014-2","article-title":"TPPU treatment of burned mice dampens inflammation and generation of bioactive DHET which impairs neutrophil function","volume":"11","author":"Bergmann","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/j.jiac.2024.07.006_bib58","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.ijid.2021.05.074","article-title":"Rapid identification of bacteria from respiratory samples of patients hospitalized in intensive care units, with FilmArray Pneumonia Panel Plus","volume":"108","author":"Cam\u00e9l\u00e9na","year":"2021","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.jiac.2024.07.006_bib59","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ijid.2023.04.003","article-title":"Determinants of poor clinical outcome in patients with influenza pneumonia: a systematic review and meta-analysis","volume":"131","author":"Escribese","year":"2023","journal-title":"Int J Infect Dis"},{"issue":"4","key":"10.1016\/j.jiac.2024.07.006_bib60","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00438-13","article-title":"Interkingdom signaling induces Streptococcus pneumoniae biofilm dispersion and transition from asymptomatic colonization to disease","volume":"4","author":"Marks","year":"2013","journal-title":"mBio"},{"issue":"5","key":"10.1016\/j.jiac.2024.07.006_bib61","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.3390\/v14051064","article-title":"The contribution of viral proteins to the synergy of influenza and bacterial Co-infection","volume":"14","author":"Miku\u0161ov\u00e1","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.jiac.2024.07.006_bib62","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1073\/pnas.1414422112","article-title":"Influenza viral neuraminidase primes bacterial coinfection through TGF-\u03b2-mediated expression of host cell receptors","volume":"112","author":"Li","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"issue":"12","key":"10.1016\/j.jiac.2024.07.006_bib63","doi-asserted-by":"crossref","first-page":"6228","DOI":"10.1111\/jcmm.13910","article-title":"Quercetin impairs Streptococcus pneumoniae biofilm formation by inhibiting sortase A activity","volume":"22","author":"Wang","year":"2018","journal-title":"J Cell Mol Med"},{"issue":"6","key":"10.1016\/j.jiac.2024.07.006_bib64","doi-asserted-by":"crossref","DOI":"10.1128\/IAI.00676-20","article-title":"Sialic acid protects nontypeable Haemophilus influenzae from natural IgM and promotes survival in murine respiratory tract","volume":"89","author":"Jackson","year":"2021","journal-title":"Infect Immun"},{"issue":"9","key":"10.1016\/j.jiac.2024.07.006_bib65","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.3390\/v13091725","article-title":"Viral and bacterial Co-infections in the lungs: dangerous liaisons","volume":"13","author":"Oliva","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.jiac.2024.07.006_bib66","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.643326","article-title":"Virus-induced changes of the respiratory tract environment promote secondary infections with Streptococcus pneumoniae","volume":"11","author":"Sender","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"3","key":"10.1016\/j.jiac.2024.07.006_bib67","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/1348-0421.12577","article-title":"Pathogenic mechanisms of invasive group A Streptococcus infections by influenza virus-group A Streptococcus superinfection","volume":"62","author":"Okamoto","year":"2018","journal-title":"Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.jiac.2024.07.006_bib68","doi-asserted-by":"crossref","first-page":"128","DOI":"10.4049\/jimmunol.2101135","article-title":"Type I IFN signaling is essential for preventing IFN-\u03b3 hyperproduction and subsequent deterioration of antibacterial immunity during postinfluenza pneumococcal infection","volume":"209","author":"Palani","year":"2022","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.jiac.2024.07.006_bib69","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1186\/s12985-020-01449-0","article-title":"Role of \u03b3\u03b4 T cells in controlling viral infections with a focus on influenza virus: implications for designing novel therapeutic approaches","volume":"17","author":"Sabbaghi","year":"2020","journal-title":"Virol J"},{"issue":"6","key":"10.1016\/j.jiac.2024.07.006_bib70","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.4049\/jimmunol.2000094","article-title":"Influenza infection induces alveolar macrophage dysfunction and thereby enables noninvasive Streptococcus pneumoniae to cause deadly pneumonia","volume":"205","author":"Verma","year":"2020","journal-title":"J Immunol"},{"issue":"11","key":"10.1016\/j.jiac.2024.07.006_bib71","doi-asserted-by":"crossref","first-page":"5486","DOI":"10.3390\/ijms22115486","article-title":"Altered signal transduction in the immune response to influenza virus and S. pneumoniae or S. aureus Co-infections","volume":"22","author":"Wilden","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.jiac.2024.07.006_bib72","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.03589-20","article-title":"Type I interferon signaling is a common factor driving Streptococcus pneumoniae and influenza A virus shedding and transmission","volume":"12","author":"Zangari","year":"2021","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.jiac.2024.07.006_bib73","doi-asserted-by":"crossref","first-page":"L158","DOI":"10.1152\/ajplung.00338.2014","article-title":"Influenza-induced type I interferon enhances susceptibility to gram-negative and gram-positive bacterial pneumonia in mice","volume":"309","author":"Lee","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.jiac.2024.07.006_bib74","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1279159","article-title":"A cooperativity between virus and bacteria during respiratory infections","volume":"14","author":"Lalbiaktluangi","year":"2023","journal-title":"Front Microbiol"},{"issue":"1","key":"10.1016\/j.jiac.2024.07.006_bib75","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/s12887-022-03508-7","article-title":"Clinical characteristics of hospitalized term and preterm infants with community-acquired viral pneumonia","volume":"22","author":"Guan","year":"2022","journal-title":"BMC Pediatr"},{"issue":"6","key":"10.1016\/j.jiac.2024.07.006_bib76","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/infdis\/jit527","article-title":"Influenza A virus exacerbates Staphylococcus aureus pneumonia in mice by attenuating antimicrobial peptide production","volume":"209","author":"Robinson","year":"2014","journal-title":"J Infect Dis"},{"issue":"9","key":"10.1016\/j.jiac.2024.07.006_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111721","article-title":"The influenza-injured lung microenvironment promotes MRSA virulence, contributing to severe secondary bacterial pneumonia","volume":"41","author":"Langou\u00ebt-Astri\u00e9","year":"2022","journal-title":"Cell Rep"},{"issue":"8","key":"10.1016\/j.jiac.2024.07.006_bib78","doi-asserted-by":"crossref","first-page":"O493","DOI":"10.1111\/1469-0691.12505","article-title":"Host immunological response and factors associated with clinical outcome in patients with the novel influenza A H7N9 infection","volume":"20","author":"Shen","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"18","key":"10.1016\/j.jiac.2024.07.006_bib79","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1042\/CS20171006","article-title":"Aspirin-triggered resolvin D1 reduces pneumococcal lung infection and inflammation in a viral and bacterial coinfection pneumonia model","volume":"131","author":"Wang","year":"2017","journal-title":"Clin Sci"},{"key":"10.1016\/j.jiac.2024.07.006_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.704427","article-title":"Protectins PCTR1 and PD1 reduce viral load and lung inflammation during respiratory syncytial virus infection in mice","volume":"12","author":"Walker","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.jiac.2024.07.006_bib81","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.01267-22","article-title":"Cysteinyl maresins reprogram macrophages to protect mice from Streptococcus pneumoniae after influenza A virus infection","volume":"13","author":"P Tavares","year":"2022","journal-title":"mBio"},{"issue":"2","key":"10.1016\/j.jiac.2024.07.006_bib82","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2206480120","article-title":"The Maresin 1-LGR6 axis decreases respiratory syncytial virus-induced lung inflammation","volume":"120","author":"Krishnamoorthy","year":"2023","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.jiac.2024.07.006_bib83","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1186\/s12967-023-04111-9","article-title":"Protectin conjugates in tissue regeneration 1 alleviates sepsis-induced acute lung injury by inhibiting ferroptosis","volume":"21","author":"Lv","year":"2023","journal-title":"J Transl Med"},{"issue":"2","key":"10.1016\/j.jiac.2024.07.006_bib84","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/imm.12206","article-title":"The role of pro-resolution lipid mediators in infectious disease","volume":"141","author":"Russell","year":"2014","journal-title":"Immunology"},{"issue":"2","key":"10.1016\/j.jiac.2024.07.006_bib85","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3390\/jof6020091","article-title":"COVID-19 associated pulmonary aspergillosis (CAPA)-From immunology to treatment","volume":"6","author":"Arastehfar","year":"2020","journal-title":"J Fungi (Basel)"},{"issue":"10","key":"10.1016\/j.jiac.2024.07.006_bib86","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1007\/s00134-021-06471-6","article-title":"Diagnosis and treatment of COVID-19 associated pulmonary apergillosis in critically ill patients: results from a European confederation of medical mycology registry","volume":"47","author":"Prattes","year":"2021","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2024.07.006_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.smim.2023.101728","article-title":"Immunity to fungi in the lung","volume":"66","author":"Heung","year":"2023","journal-title":"Semin Immunol"},{"key":"10.1016\/j.jiac.2024.07.006_bib88","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1146\/annurev-immunol-101220-034306","article-title":"Immunity to invasive fungal diseases","volume":"40","author":"Casadevall","year":"2022","journal-title":"Annu Rev Immunol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24001843?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X24001843?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T00:33:36Z","timestamp":1724373216000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X24001843"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":88,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S1341321X24001843"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2024.07.006","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Are secondary bacterial pneumonia mortalities increased because of insufficient pro-resolving mediators?","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2024.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese Society of Chemotherapy, Japanese Association for Infectious Diseases, and Japanese Society for Infection Prevention and Control. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}